Earnings Call · Q3 FY2022·2022-11-15

Q3 22EPS +43.75%·Rev n/aQ2 22EPS -50.00%·Rev n/aQ1 22EPS 0.00%·Rev n/aQ4 21EPS -77.78%·Rev n/a⚠ consensus missing

Sanara MedTech Inc. SMTI

Callon Nichols — Director of Investor Relations

Ronald Nixon — Chief Executive Officer

Zachary Fleming — Sales or Marketing Executive (likely VP or similar)

Michael McNeil — Chief Financial Officer

−0.7%1d on move date+0.2% vs SPY3d+12.4%5d+7.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SMTI calls or request research access.

More SMTI calls Browse calls Request research access